InsightsKnowledge BaseSurgical & Medical Robots
Healthcare Robotics

Surgical & Medical Robots

Precision robotic systems for minimally invasive surgery

5
L5 — Mainstream
Market Size
$14.2B (2024)
Growth Rate
+15% YoY
CAGR
15%
Time to Mainstream
Already mainstream

Market Overview

Surgical robots enable minimally invasive procedures with greater precision, smaller incisions, and faster patient recovery than traditional surgery. The market is dominated by Intuitive Surgical's da Vinci system, but a new generation of competitors — Medtronic Hugo, CMR Surgical Versius, Johnson & Johnson Ottava — is challenging the monopoly. The sector is expanding from soft tissue surgery into orthopedics, neurosurgery, and endoscopy.

Key Use Cases

Laparoscopic surgery
Prostatectomy
Hysterectomy
Knee and hip replacement
Spinal surgery
Colorectal surgery

Key Challenges

High system cost ($1–2M per unit)
Surgeon training requirements
Reimbursement coverage variability
Maintenance and service complexity

Strategic Implication

Surgical robotics is the most commercially mature segment of healthcare robotics. The market is transitioning from monopoly (Intuitive Surgical) to competitive multi-vendor landscape, creating procurement opportunities for hospitals seeking cost-competitive alternatives.

Key Players

Intuitive Surgical (da Vinci)
Medtronic (Hugo)
CMR Surgical (Versius)
Stryker (Mako)
Zimmer Biomet (ROSA)
J&J (Ottava)

Interested in deploying this technology?

Contact BIT →View Solutions Portfolio
← Back to Knowledge BaseBIT Intelligence Platform · Last updated: March 2026
BIT Logo
BIT
Bravo Intelligence & Technology AS
Karl Johans gate 25
0159 Oslo, Norway
Org.nr. 932 749 726
[email protected]
Solutions
Company
Contact
Legal
Stay Informed

Receive updates on BIT technology, partnerships, and milestones.

Legal, Ethics & Compliance
Intellectual Property
All content, designs, specifications, concepts, and innovations presented on this website are the exclusive intellectual property of Bravo Intelligence and Technology (BIT). Unauthorised reproduction, distribution, or use is strictly prohibited.
Confidentiality
All partnership inquiries, investor communications, and technical disclosures are treated as strictly confidential. A Non-Disclosure Agreement (NDA) will be required prior to any detailed exchange of proprietary information.
Global Ethics & Responsible Use
BIT is committed to the responsible development and deployment of autonomous systems. All products are designed and produced in accordance with international humanitarian law, applicable export control regulations, and recognised ethical standards for AI and autonomous technology.
Regulatory Compliance
BIT operates in full compliance with Norwegian law, European Union regulations, and applicable international standards including ISO 9001, ITAR, and relevant defence procurement frameworks.
Information Security
BIT applies strict information security protocols across all operations. This website does not disclose classified product details, production locations, or strategic partner identities.
Air. Land. Sea. Nano. — The Future is Autonomous.
© 2026 Bravo Intelligence and Technology. All rights reserved.